Logo

Memorial Sloan-Kettering

DLP Plus Single-Cell Sequencing Method Spreads From Canada to Cancer Labs Worldwide
Premium

The British Columbia-based developers are not trying to commercialize DLP Plus, but the platform is now being adopted in the US and UK.

Researchers Force Nanopore Sequencing to Go Short-Read for Copy Number Analysis in Cancer
Premium

Using Oxford Nanopore's MinIon to sequence molecules about 500 bp long, researchers were able to detect copy number aberrations in AML.

MSK Fellows Develop Online Resource to Increase Awareness of Genetic Cascade Testing
Premium

They hope the website will be an unbiased source for genetic risk information, testing, and financial support services and spur cascade testing in families.

FDA Recognizes Portion of MSK Oncology Knowledge Base in Public Human Genetic Variant Database

MSK's OncoKB is the first collection of somatic variants that the FDA has accepted for test developers to use in premarket validation studies.

GNS Healthcare Joins Memorial Sloan Kettering Innovation Hub for Precision Oncology

The collaboration uses virtual patients built with multiomic and clinical data to identify aggressive disease subtypes and discover new drug targets.

Jul 13, 2021

Gastric Cancer Cases Frequently Harbor Genetic Risk Variants, Suggesting Germline Testing

May 24, 2021

AACR Presentations Highlight Power of Large Tumor Atlases in Studies of Cancer Progression
Premium

Mar 26, 2021

Genome Sequencing Identifies Myeloma Precursor Disease With High Progression Risk

Feb 18, 2021

MSK Study Underscores Need to Validate Cancer-Specific Tumor Mutational Burden Cutoffs
Premium

Feb 16, 2021

MSK Team Explores Clinical Utility of Germline Testing for Pediatric Cancer Patients

Nov 24, 2020

Clinicians Face New Intervention Questions as Clonal Hematopoiesis Mutation Data Evolves
Premium

Nov 18, 2020

MSK Study Suggests Germline Tests May Miss Mosaic Cancer Risk Mutations in Some Patients
Premium

Oct 29, 2020

Single-Cell Analysis Elucidates Mutation Patterns in Myeloid Malignancies

Oct 27, 2020

Clonal Hematopoiesis Mutation Study Reveals Risk of Treatment-Related Cancer

Oct 7, 2020

Immunotherapy Response Prediction Improved by Baseline, On-Treatment Biomarker Combo
Premium

Sep 18, 2020

MSK Clonal Hematopoiesis Clinic Aims to Drive New Strategies for Cancer Risk Assessment, Prevention
Premium

Sep 17, 2020

New York City Opening Dedicated COVID-19 Testing Laboratory

Sep 10, 2020

Epic Sciences, MSK Identify Potential Prostate Cancer Therapy Response Biomarker
Premium

Sep 4, 2020

Mutations in FOXA1 Gene Can Affect Breast Cancer Patients' Response to Therapy

Jul 1, 2020

Polygenic Risk Score Modifies Breast Cancer Risk in Pathogenic Variant Carriers

Jun 11, 2020

'Very Fast' CRISPR Enables Immediate, Synchronous Cleavage of Genomic Sites

May 31, 2020

Germline Results From Tumor-Normal Sequencing Guides Precision Therapy in Advanced Cancer Patients

May 31, 2020

Polygenic Risk Score, Family History Refine Breast Cancer Risk Assessment in CHEK2 Mutation Carriers

Apr 30, 2020

Prostate Cells With Regenerative Capability Uncovered by Single-Cell Transcriptomics

Apr 16, 2020

Human Tumor Atlas Network Team Shares Strategy for Tracking Tumor Transitions

Breaking News
The Scan

Transplant Tests Edited Pig Kidneys

The Associated Press reports a University of Alabama-Birmingham team transplanted genetically modified pig kidneys into a brain-dead human patient.

UK Changes Some Gene-Edited Crop Rules

A new law may enable gene-edited crops to be sold in the UK within about five years, New Scientist says.

Pill Works Against Omicron in Lab

Pfizer's antiviral pill to treat SARS-CoV-2 appears to work against the Omicron variant, the Wall Street Journal reports.

Nature Papers Find Genetic Risk Factor for Smell, Taste Loss in COVID-19; Analyze TB Granulomas

In Nature this week: genome-wide association study find locus linked to the risk COVID-19 patients losing their sense of taste or smell, and more.